• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然产物与癌症治疗的相互作用:潜在机制和临床重要性。

Interactions between natural products and cancer treatments: underlying mechanisms and clinical importance.

机构信息

Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia.

Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, 27599, USA.

出版信息

Cancer Chemother Pharmacol. 2023 Feb;91(2):103-119. doi: 10.1007/s00280-023-04504-z. Epub 2023 Jan 27.

DOI:10.1007/s00280-023-04504-z
PMID:36707434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9905199/
Abstract

Natural products, also referred to as dietary supplements, complementary and alternative medicines, and health or food supplements are widely used by people living with cancer. These products are predominantly self-selected and taken concurrently with cancer treatments with the intention of improving quality of life, immune function and reducing cancer symptoms and treatment side effects. Concerns have been raised that concurrent use may lead to interactions resulting in adverse effects and unintended treatment outcomes. This review provides an overview of the mechanisms by which these interactions can occur and the current evidence about specific clinically important natural product-drug interactions. Clinical studies investigating pharmacokinetic interactions provide evidence that negative treatment outcomes may occur when Hypericum perforatum, Grapefruit, Schisandra sphenanthera, Curcuma longa or Hydrastis canadensis are taken concurrently with common cancer treatments. Conversely, pharmacodynamic interactions between Hangeshashinto (TJ-14) and some cancer treatments have been shown to reduce the side effects of diarrhoea and oral mucositis. In summary, research in this area is limited and requires further investigation.

摘要

天然产物,也被称为膳食补充剂、补充和替代药物以及健康或食品补充剂,被癌症患者广泛使用。这些产品主要是自我选择的,并与癌症治疗同时使用,目的是提高生活质量、免疫功能,减轻癌症症状和治疗副作用。人们担心同时使用可能会导致相互作用,从而产生不良反应和意想不到的治疗结果。本综述概述了这些相互作用发生的机制以及关于特定临床重要的天然产物-药物相互作用的现有证据。研究药代动力学相互作用的临床研究提供了证据表明,贯叶金丝桃、葡萄柚、五味子、姜黄或升麻与常见癌症治疗同时使用时,可能会导致治疗结果不佳。相反,汉方制剂(TJ-14)与某些癌症治疗之间的药效学相互作用已被证明可以减轻腹泻和口腔粘膜炎的副作用。总之,该领域的研究有限,需要进一步调查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/069f/9905199/9a64d1ba874b/280_2023_4504_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/069f/9905199/779a4d452211/280_2023_4504_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/069f/9905199/9a64d1ba874b/280_2023_4504_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/069f/9905199/779a4d452211/280_2023_4504_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/069f/9905199/9a64d1ba874b/280_2023_4504_Fig2_HTML.jpg

相似文献

1
Interactions between natural products and cancer treatments: underlying mechanisms and clinical importance.天然产物与癌症治疗的相互作用:潜在机制和临床重要性。
Cancer Chemother Pharmacol. 2023 Feb;91(2):103-119. doi: 10.1007/s00280-023-04504-z. Epub 2023 Jan 27.
2
Pharmacokinetic herb-drug interactions (part 2): drug interactions involving popular botanical dietary supplements and their clinical relevance.药代动力学的草药-药物相互作用(第 2 部分):涉及常用植物性膳食补充剂的药物相互作用及其临床相关性。
Planta Med. 2012 Sep;78(13):1490-514. doi: 10.1055/s-0031-1298331. Epub 2012 May 7.
3
Herbal supplements interactions with oral oestrogen-based contraceptive metabolism and transport.草药补充剂与口服雌激素类避孕药的代谢和转运相互作用。
Phytother Res. 2020 Jul;34(7):1519-1529. doi: 10.1002/ptr.6623. Epub 2020 Feb 3.
4
Interactions between antiretroviral therapy and complementary and alternative medicine: a narrative review.抗逆转录病毒疗法与补充和替代医学的相互作用:叙事性综述。
Clin Microbiol Infect. 2020 Sep;26(9):1161-1170. doi: 10.1016/j.cmi.2020.04.019. Epub 2020 Apr 28.
5
Is the clinical relevance of drug-food and drug-herb interactions limited to grapefruit juice and Saint-John's Wort?药物与食物及药物与草药相互作用的临床相关性是否仅限于葡萄柚汁和圣约翰草?
Pharmacol Res. 2017 Apr;118:82-92. doi: 10.1016/j.phrs.2016.09.038. Epub 2016 Sep 28.
6
Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic.在记忆门诊就诊的老年人所使用的草药与传统药物疗法之间的潜在相互作用。
Drugs Aging. 2002;19(11):879-86. doi: 10.2165/00002512-200219110-00005.
7
Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study.美国-墨西哥边境地区老年人多重用药、多种草药使用、营养补充剂使用情况及潜在产品相互作用的患病率:一项基于问卷调查的描述性研究。
Drugs Aging. 2009;26(5):423-36. doi: 10.2165/00002512-200926050-00006.
8
Clinical herbal interactions with conventional drugs: from molecules to maladies.临床草药与常规药物的相互作用:从分子到疾病。
Curr Med Chem. 2011;18(31):4836-50. doi: 10.2174/092986711797535317.
9
Potential interactions of drug-natural health products and natural health products-natural health products among children.儿童中药物-天然健康产品以及天然健康产品-天然健康产品之间的潜在相互作用。
J Pediatr. 2008 Apr;152(4):521-6, 526.e1-4. doi: 10.1016/j.jpeds.2007.09.026. Epub 2007 Nov 7.
10
Natural Health Product-Drug Interaction Causality Assessment in Pediatric Adverse Event Reports Associated with Attention-Deficit/Hyperactivity Disorder Medication.与注意缺陷多动障碍药物相关的儿科不良事件报告中的天然健康产品-药物相互作用因果关系评估。
J Child Adolesc Psychopharmacol. 2020 Feb;30(1):38-47. doi: 10.1089/cap.2019.0102. Epub 2019 Nov 22.

引用本文的文献

1
Artesunate regulates malignant progression of breast cancer cells via lncRNA TUG1/miR-145-5p/HOXA5 axis.青蒿琥酯通过lncRNA TUG1/miR-145-5p/HOXA5轴调节乳腺癌细胞的恶性进展。
PLoS One. 2025 Aug 4;20(8):e0329490. doi: 10.1371/journal.pone.0329490. eCollection 2025.
2
Exploring Phytochemical Adjuvant Therapy in Melanoma Treatment: The Effects of MAZ-51 and Zingerone on Melanoma Cell Proliferation.探索植物化学辅助疗法在黑色素瘤治疗中的应用:MAZ-51和姜辣素对黑色素瘤细胞增殖的影响。
Clin Exp Pharmacol Physiol. 2025 Sep;52(9):e70059. doi: 10.1111/1440-1681.70059.
3
Herb-drug interactions in oncology: pharmacodynamic/pharmacokinetic mechanisms and risk prediction.

本文引用的文献

1
The influence of green tea extract on nintedanib's bioavailability in patients with pulmonary fibrosis.绿茶提取物对肺纤维化患者尼达尼布生物利用度的影响。
Biomed Pharmacother. 2022 Jul;151:113101. doi: 10.1016/j.biopha.2022.113101. Epub 2022 May 17.
2
Effect of hepar-protecting Wuzhi capsule on pharmacokinetics and dose-effect character of tacrolimus in healthy volunteers.肝素保护乌质胶囊对健康志愿者他克莫司药代动力学及剂量效应特征的影响。
Biopharm Drug Dispos. 2022 Aug;43(4):119-129. doi: 10.1002/bdd.2312. Epub 2022 Aug 27.
3
A phase I evaluation of the effect of curcumin on dose-limiting toxicity and pharmacokinetics of irinotecan in participants with solid tumors.
肿瘤学中的草药-药物相互作用:药效学/药代动力学机制及风险预测
Chin Med. 2025 Jul 7;20(1):107. doi: 10.1186/s13020-025-01156-4.
4
Predictive Modeling of Pharmacokinetic Drug-Drug and Herb-Drug Interactions in Oncology: Insights From PBPK Studies.肿瘤学中药代动力学药物-药物及草药-药物相互作用的预测模型:基于生理药代动力学研究的见解
Int J Toxicol. 2025 Jun 11;44(5):10915818251345116. doi: 10.1177/10915818251345116.
5
Characterization and interactions between piperine and ezetimibe in their Anti-hyperlipidemic efficacy using Biopharmaceutics and Pharmacokinetics.利用生物药剂学和药代动力学研究胡椒碱与依折麦布在抗高血脂疗效方面的特性及相互作用。
BMC Pharmacol Toxicol. 2025 Jan 14;26(1):7. doi: 10.1186/s40360-025-00836-z.
6
Epimesatines P-S: Four Undescribed Flavonoids from Maxim. and Their Cytotoxicity Activities.Epimesatines P-S:来自醉鱼草属植物的四个未描述的类黄酮及其细胞毒性活性。
Molecules. 2024 Oct 4;29(19):4711. doi: 10.3390/molecules29194711.
7
Traditional and Complementary Medicine Use among Cancer Patients in Asian Countries: A Systematic Review and Meta-Analysis.亚洲国家癌症患者使用传统医学和补充医学的情况:一项系统评价与荟萃分析
Cancers (Basel). 2024 Sep 11;16(18):3130. doi: 10.3390/cancers16183130.
8
Design, Synthesis, and Anticancer Activity of Novel Enmein-Type Diterpenoid Derivatives Targeting the PI3K/Akt/mTOR Signaling Pathway.新型莪术二萜类衍生物的设计、合成及靶向 PI3K/Akt/mTOR 信号通路的抗癌活性。
Molecules. 2024 Aug 27;29(17):4066. doi: 10.3390/molecules29174066.
9
Mistletoe Extract in Patients With Advanced Pancreatic Cancer: a Double-Blind, Randomized, Placebo-Controlled Tial (MISTRAL).在晚期胰腺癌患者中使用槲寄生提取物:一项双盲、随机、安慰剂对照试验(MISTRAL)。
Dtsch Arztebl Int. 2024 May 31;121(11):347-354. doi: 10.3238/arztebl.m2024.0080.
10
Assessment of Integrative Therapeutic Methods for Improving the Quality of Life and Functioning in Cancer Patients-A Systematic Review.评估改善癌症患者生活质量和功能的综合治疗方法——一项系统综述
J Clin Med. 2024 Feb 20;13(5):1190. doi: 10.3390/jcm13051190.
一项关于姜黄素对实体瘤患者伊立替康剂量限制性毒性和药代动力学影响的 I 期评估。
Clin Transl Sci. 2022 May;15(5):1304-1315. doi: 10.1111/cts.13250. Epub 2022 Feb 26.
4
: A Comprehensive Review of its Botany, Phytochemistry, Pharmacology, and Clinical Applications.对其植物学、植物化学、药理学及临床应用的全面综述。
Am J Chin Med. 2021;49(7):1577-1622. doi: 10.1142/S0192415X21500749. Epub 2021 Sep 23.
5
Effects and safety evaluation of Wuzhi Capsules combined with tacrolimus for the treatment of kidney transplantation recipients.五酯胶囊联合他克莫司治疗肾移植受者的效果及安全性评价。
J Clin Pharm Ther. 2021 Dec;46(6):1636-1649. doi: 10.1111/jcpt.13493. Epub 2021 Aug 3.
6
Quantitative Investigation of Irinotecan Metabolism, Transport, and Gut Microbiome Activation.伊立替康代谢、转运和肠道微生物组激活的定量研究。
Drug Metab Dispos. 2021 Aug;49(8):683-693. doi: 10.1124/dmd.121.000476. Epub 2021 Jun 1.
7
Modeling Pharmacokinetic Natural Product-Drug Interactions for Decision-Making: A NaPDI Center Recommended Approach.建立药代动力学天然产物-药物相互作用模型以辅助决策:NaPDI 中心推荐方法。
Pharmacol Rev. 2021 Apr;73(2):847-859. doi: 10.1124/pharmrev.120.000106.
8
A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.一项关于 PHY906 联合卡培他滨治疗肝细胞癌的 II 期临床试验。
Oncologist. 2021 Mar;26(3):e367-e373. doi: 10.1002/onco.13582. Epub 2020 Nov 25.
9
Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen.绿茶摄入量对接受他莫昔芬治疗的乳腺癌患者中内美通稳态浓度的影响。
Breast Cancer Res Treat. 2020 Nov;184(1):107-113. doi: 10.1007/s10549-020-05829-6. Epub 2020 Aug 16.
10
Goldenseal (Hydrastis canadensis L.) and its active constituents: A critical review of their efficacy and toxicological issues.白毛茛(Hydrastis canadensis L.)及其活性成分:对其疗效和毒理学问题的批判性评价。
Pharmacol Res. 2020 Oct;160:105085. doi: 10.1016/j.phrs.2020.105085. Epub 2020 Jul 16.